APA

Gray J. E., Chiappori A., Williams C. C., Tanvetyanon T., Haura E. B., Creelan B. C., Kim J., Boyle T. A., Pinder-Schenck M., Khalil F., Altiok S., Devane R., Noyes D., Mediavilla-Varela M., Smilee R., Hopewell E. L., Kelley L. & Antonia S. J. (20190318). A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma. : Cancer immunology, immunotherapy : CII.

Chicago

Gray Jhanelle E, Chiappori Alberto, Williams Charlie C, Tanvetyanon Tawee, Haura Eric B, Creelan Ben C, Kim Jongphil, Boyle Theresa A, Pinder-Schenck Mary, Khalil Farah, Altiok Soner, Devane Rebecca, Noyes David, Mediavilla-Varela Melanie, Smilee Renee, Hopewell Emily L, Kelley Linda and Antonia Scott J. 20190318. A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma. : Cancer immunology, immunotherapy : CII.

Harvard

Gray J. E., Chiappori A., Williams C. C., Tanvetyanon T., Haura E. B., Creelan B. C., Kim J., Boyle T. A., Pinder-Schenck M., Khalil F., Altiok S., Devane R., Noyes D., Mediavilla-Varela M., Smilee R., Hopewell E. L., Kelley L. and Antonia S. J. (20190318). A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma. : Cancer immunology, immunotherapy : CII.

MLA

Gray Jhanelle E, Chiappori Alberto, Williams Charlie C, Tanvetyanon Tawee, Haura Eric B, Creelan Ben C, Kim Jongphil, Boyle Theresa A, Pinder-Schenck Mary, Khalil Farah, Altiok Soner, Devane Rebecca, Noyes David, Mediavilla-Varela Melanie, Smilee Renee, Hopewell Emily L, Kelley Linda and Antonia Scott J. A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma. : Cancer immunology, immunotherapy : CII. 20190318.